Wolverine Asset Management’s Calidi Biotherapeutics, Inc. Redeemable Warrants, each whole warrant exercisable for 1/10th of a share of Common Stock at an exercise price of $115.00 CLDI.WS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-5,229
| Closed | -$261 | – | 1612 |
|
|
2023
Q4 | $261 | Sell |
5,229
-60,882
| -92% | -$3.04K | ﹤0.01% | 1253 |
|
|
2023
Q3 | $14.5K | Sell |
66,111
-18,470
| -22% | -$4.06K | ﹤0.01% | 1026 |
|
|
2023
Q2 | $11K | Hold |
84,581
| – | – | ﹤0.01% | 1008 |
|
|
2023
Q1 | $3.47K | Hold |
84,581
| – | – | ﹤0.01% | 1244 |
|
|
2022
Q4 | $4.23K | Hold |
84,581
| – | – | ﹤0.01% | 1376 |
|
|
2022
Q3 | $4K | Hold |
84,581
| – | – | ﹤0.01% | 1821 |
|
|
2022
Q2 | $7K | Hold |
84,581
| – | – | ﹤0.01% | 1774 |
|
|
2022
Q1 | $30K | Sell |
84,581
-29,786
| -26% | -$10.6K | ﹤0.01% | 1437 |
|
|
2021
Q4 | $57K | Buy |
+114,367
| New | +$57K | ﹤0.01% | 1193 |
|